Precision Medicine

Discover key insights into how automated HPLC systems provide reliable A1c results with detection of commonly occurring hemoglobin variants for optimum management of diabetes

Screening successes, emerging technologies, precision treatments, and other steps forward from the AACR Cancer Progress Report 2024

Steps that buttress biomarker analysis include laboratories adopting platform-agnostic technologies

A new interdisciplinary project at Lehigh University aims to leverage AI and advanced modeling to refine CRISPR gene editing, enhancing safety and expanding its medical applications

A Strategic Guide for Clinical Labs to Stay Compliant and Thrive Amid Regulatory Changes

Patient-derived xenograft models enable researchers to explore novel therapies and diagnostic tools within the context of specific mutational signatures, treatment histories, and more

By using 3D mini tumor models that closely resemble a patient's tumor, treatments could be tailored more effectively, paving the way for more personalized cancer treatments

Discover how ultrapure water enhances sensitivity, traceability, and reliability in LC-MS for clinical laboratories

New CLIA-certified lab ensures seamless transition from early assay development and testing to full companion diagnostics commercialization

Top experts publish the first standardized guidelines for reporting precision medicine research

An analytical tool called EV fingerprinting could soon replace traditional invasive biopsies for certain diseases

Learn about the role of automation in optimizing FFPE nucleic acid extraction, improving workflow efficiency and reliability

Improve nucleic acid yield and reliability with automation-friendly genomic profiling 

The new platform will help researchers better understand cell-to-cell interactions in tumor microenvironments, benefitting future development of targeted cancer therapies

​​​​​​New research highlights the feasibility of testing for lingering cancer cells for patients in remission from acute myeloid leukemia

Integrating epigenetic insights into cancer research could help deliver personalized, high-quality, and cost-effective patient care

When combined with CA 19-9, the novel biopsy accurately detected 97 percent of stage 1–2 pancreatic cancers

Increasing Phase 2 clinical trial cancellations can have a long-drawn and multifold impact on clinical research

The Plasma Detect™ is the first clinically validated, whole-genome sequencing MRD solution for early-stage colon cancer

A blood test will be better than nothing, but may lead to more CRC cases and deaths than established screening tests